Melanotan II in Santa Barbara, CA Eternity Health Partners In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Nasal tanning sprays linked to skin cancer, trading standards officers warn Consumer affairs The Guardian FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure Emerging Threat: Melanotan, Repackaging, and Online Sales